StemX Bio

Leiden, The Netherlands

StemX Bio is specializing in transforming diabetes drug by developing revolutionary 3D pancreatic microtissue technology.

$410K raised

Oct 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has StemX Bio raised?

StemX Bio has raised $410K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2025.

Who are StemX Bio's investors?

StemX Bio's investors include UNIIQ, LEH.

Where is StemX Bio headquartered?

StemX Bio is headquartered in Leiden, The Netherlands.

What does StemX Bio do?

StemX Bio is specializing in transforming diabetes drug by developing revolutionary 3D pancreatic microtissue technology.

What stage is StemX Bio at?

StemX Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 6, 2025.

MLA

"StemX Bio — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/stemx-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). StemX Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/stemx-bio

Wikipedia (cite web)

{{cite web |title=StemX Bio — Funding & Investors |url=https://www.vcbacked.co/company/stemx-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 6, 2025.